Reduced <em>MIR130A</em> is involved in primary immune thrombocytopenia via targeting <em>TGFB1</em> and <em>IL18</em>
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest